Alcosta Capital Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Alcosta Capital Management’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,470	Closed	-$2.15M	–	35
2022 Q4	$2.15M	Sell	10,470 -272	-3%	-$68.8K	2.17%	26
2022 Q3	$2.99M	Buy	+10,742	New	+$2.73M	2.93%	17

Other funds holding SWAV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Alcosta Capital Management's SWAV Position: Q1 2023 in Review

Alcosta Capital Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q1 2023, closing a stake of 10,470 shares — an estimated $2.15M sold.

Alcosta Capital Management first reported a position in SWAV in Q3 2022 and held it in 2 quarters. The position peaked at $2.99M in Q3 2022. 381 funds tracked by Wall St. Rank hold SWAV as of Q1 2023.

Alcosta Capital Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Alcosta Capital Management sold 10,470 Shockwave Medical, Inc. Common Stock shares in Q1 2023, an estimated $2.15M.
Alcosta Capital Management first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Alcosta Capital Management's Shockwave Medical, Inc. Common Stock position peaked at $2.99M in Q3 2022.
381 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q1 2023.

Based on Alcosta Capital Management's 13F filing for Q1 2023, filed 12 May 2023.